Shang Yinghui, Wang Qinghai, Li Jian, Zhao Qiangqiang, Huang Xueyuan, Dong Hang, Liu Haiting, Zhang Ye, Zhang Junhua, Gui Rong, Nie Xinmin
Department of Blood Transfusion, The Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Department of Cardiology, The Second Hospital of Shandong University, Jinan, People's Republic of China.
Onco Targets Ther. 2020 Jan 15;13:473-486. doi: 10.2147/OTT.S232594. eCollection 2020.
Isatin derivatives have extensive biological activities, such as antitumor. IF203, a novel isatin derivative, has not previously been reported to have antitumor activity.
Acid phosphatase assays (APAs) and Ki-67 immunohistochemistry were used to detect the proliferation of HepG2 cells. Transmission electron microscope (TEM) was applied to detect ultrastructural changes. Flow cytometry (FCM) was used to detect cell cycle, apoptosis, reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) of HepG2 cells in vitro. TUNEL, MMP and ROS immunofluorescence assays were applied to assess apoptosis, MMP, and ROS of HepG2 cells in vivo. Western Blotting was applied to assess the levels of apoptosis- and autophagy-related proteins.
In this study, in vivo and in vitro experiments showed that IF203 possesses antitumor activity. The results of APAs and Ki-67 immunohistochemistry demonstrated that IF203 could inhibit the proliferation of HepG2 cells. Cell cycle assays, downregulation of Cyclin B1 and Cdc2, and upregulation of P53 suggested that IF203 could lead to G2/M cell cycle arrest. In addition, ultrastructural changes, apoptosis assays, TUNEL immunofluorescence results, upregulated expression of Bax, and downregulated expression of Bcl-2 suggest that IF203 can induce apoptosis in HepG2 cells. After IF203 treatment, intracellular ROS levels increased, MMP decreased, JC-1 green fluorescence was enhanced, and the levels of Caspase-9, Caspase-3 and Cytochrome C expression were upregulated, suggesting that IF203 could induce apoptosis of HepG2 cells through the mitochondrial apoptosis pathway. Moreover, characteristic apoptotic ultrastructural changes were accompanied by the appearance of many autophagy bubbles and upregulation of Atg5, Atg12, ULK1, Beclin-1 and LC3-II proteins, suggesting that IF203 could induce autophagy in HepG2 cells.
This study showed that IF203 leads to the death of HepG2 cells through cell cycle arrest, apoptotic induction, and autophagy promotion.
异吲哚酮衍生物具有广泛的生物活性,如抗肿瘤活性。IF203是一种新型异吲哚酮衍生物,此前尚未报道其具有抗肿瘤活性。
采用酸性磷酸酶检测(APAs)和Ki-67免疫组化法检测HepG2细胞的增殖情况。应用透射电子显微镜(TEM)检测超微结构变化。采用流式细胞术(FCM)检测体外培养的HepG2细胞的细胞周期、凋亡、活性氧(ROS)和线粒体膜电位(MMP)。应用TUNEL、MMP和ROS免疫荧光检测法评估体内HepG2细胞的凋亡、MMP和ROS情况。采用蛋白质免疫印迹法评估凋亡和自噬相关蛋白的水平。
在本研究中,体内和体外实验表明IF203具有抗肿瘤活性。APAs和Ki-67免疫组化结果表明IF203可抑制HepG2细胞的增殖。细胞周期检测、细胞周期蛋白B1(Cyclin B1)和细胞分裂周期蛋白2(Cdc2)的下调以及P53的上调表明IF203可导致G2/M期细胞周期阻滞。此外,超微结构变化、凋亡检测、TUNEL免疫荧光结果、促凋亡蛋白Bax表达上调和抗凋亡蛋白Bcl-2表达下调表明IF203可诱导HepG2细胞凋亡。IF203处理后,细胞内ROS水平升高,MMP降低,JC-1绿色荧光增强,半胱天冬酶-9(Caspase-9)、半胱天冬酶-3(Caspase-3)和细胞色素C表达水平上调,表明IF203可通过线粒体凋亡途径诱导HepG2细胞凋亡。此外,特征性凋亡超微结构变化伴随着许多自噬泡的出现以及自噬相关蛋白Atg5、Atg12、ULK1、Beclin-1和微管相关蛋白1轻链3-II(LC3-II)表达上调,表明IF203可诱导HepG2细胞发生自噬。
本研究表明,IF203通过细胞周期阻滞、诱导凋亡和促进自噬导致HepG2细胞死亡。